Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

ULK1 O-GlcNAcylation Is Crucial for Activating VPS34 via ATG14L during Autophagy Initiation.

Cell reports | 2018

Unc-51-like-kinase 1 (ULK1) is a target of both the mechanistic target of rapamycin (mTOR) and AMP-activated protein kinase (AMPK), whose role is to facilitate the initiation of autophagy in response to starvation. Upon glucose starvation, dissociation of mTOR from ULK1 and phosphorylation by AMPK leads to the activation of ULK1 activity. Here, we provide evidence that ULK1 is the attachment of O-linked N-acetylglucosamine (O-GlcNAcylated) on the threonine 754 site by O-linked N-acetylglucosamine transferase (OGT) upon glucose starvation. ULK1 O-GlcNAcylation occurs after dephosphorylation of adjacent mTOR-dependent phosphorylation on the serine 757 site by protein phosphatase 1 (PP1) and phosphorylation by AMPK. ULK1 O-GlcNAcylation is crucial for binding and phosphorylation of ATG14L, allowing the activation of lipid kinase VPS34 and leading to the production of phosphatidylinositol-(3)-phosphate (PI(3)P), which is required for phagophore formation and initiation of autophagy. Our findings provide insights into the crosstalk between dephosphorylation and O-GlcNAcylation during autophagy and specify a molecular framework for potential therapeutic intervention in autophagy-related diseases.

Pubmed ID: 30517873 RIS Download

Additional research tools detected in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


PPP5C Antibody (antibody)

RRID:AB_2168771

This unknown targets PPP5C

View all literature mentions

LC3B Antibody (antibody)

RRID:AB_10003146

This polyclonal targets LC3B

View all literature mentions

PP1 (E-9) (antibody)

RRID:AB_628177

This monoclonal targets PP1 (E-9)

View all literature mentions

ATG101 antibody (antibody)

RRID:AB_10860488

This polyclonal targets ATG101 antibody

View all literature mentions

Anti-ATG13 antibody produced in rabbit (antibody)

RRID:AB_10602787

This polyclonal targets ATG13 antibody produced in rabbit

View all literature mentions

OGT / O-Linked N-Acetylglucosamine Transferase antibody (antibody)

RRID:AB_10680015

This polyclonal targets OGT / O-Linked N-Acetylglucosamine Transferase antibody

View all literature mentions

Beclin 1 Antibody (antibody)

RRID:AB_1201249

This polyclonal targets Beclin 1

View all literature mentions

PPP5C Antibody (antibody)

RRID:AB_2168771

This unknown targets PPP5C

View all literature mentions

OGT / O-Linked N-Acetylglucosamine Transferase antibody (antibody)

RRID:AB_10680015

This polyclonal targets OGT / O-Linked N-Acetylglucosamine Transferase antibody

View all literature mentions

ATG101 antibody (antibody)

RRID:AB_10860488

This polyclonal targets ATG101 antibody

View all literature mentions

PP1 (E-9) (antibody)

RRID:AB_628177

This monoclonal targets PP1 (E-9)

View all literature mentions

Anti-ATG13 antibody produced in rabbit (antibody)

RRID:AB_10602787

This polyclonal targets ATG13 antibody produced in rabbit

View all literature mentions

LC3B Antibody (antibody)

RRID:AB_10003146

This polyclonal targets LC3B

View all literature mentions

Beclin 1 Antibody (antibody)

RRID:AB_1201249

This polyclonal targets Beclin 1

View all literature mentions